Zenzedi Shortage 2025. Azurity pharmaceuticals has recalled some of its adhd and narcolepsy medication, zenzedi, after incorrect pills were found in a package of the drug. Issued a recall for one lot of zenzedi, a drug used to treat adhd and narcolepsy, the fda reported.
Is voluntarily recalling one (1) lot (f230169a) of zenzedi ® cii (dextroamphetamine sulfate tablets,. Teva pharmaceuticals, a major manufacturer of adhd medications, has resolved all of its shortages after certain doses were unavailable for several months, according to the.
The Recalled Products — A Part Of Lot Number F230169A — Expire In June 2025 And Were Recalled On Jan.
The food and drug administration announced manufacturer azurity pharmaceuticals’ voluntary recall wednesday, saying “a pharmacist in nebraska.
The Recall Notice, Issued On Wednesday, Specifies That One Lot Of Zenzedi 30 Milligram Tablets Is Being Recalled After A Pharmacist Identified Tablets Of Carbinoxamine.
The recall notice said that people who take carbinoxamine instead of zenzedi have a higher risk for accidents or injuries and may have drowsiness, increased.
Zenzedi Shortage 2025 Images References :
Issued A Recall For One Lot Of Zenzedi, A Drug Used To Treat Adhd And Narcolepsy, The Fda Reported.
Is voluntarily recalling one (1) lot (f230169a) of zenzedi®.
The Recall Comes Amid An Ongoing National Shortage Of Adhd Drugs, Creating Further Frustration For People With Adhd Who Have Struggled To Find Medications.
The recall notice, issued wednesday, says that one lot of zenzedi 30 milligram tablets is being recalled after an incident in which a pharmacist found tablets of carbinoxamine.